Bender Robert & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $393K | Hold |
2,819
| – | – | 0.09% | 34 |
|
|
2025
Q4 | $346K | Hold |
2,819
| – | – | 0.07% | 36 |
|
|
2025
Q3 | $313K | Sell |
2,819
-50
| -2% | -$5.68K | 0.07% | 39 |
|
|
2025
Q2 | $318K | Sell |
2,869
-18
| -0.6% | -$1.92K | 0.07% | 37 |
|
|
2025
Q1 | $323K | Sell |
2,887
-7,476
| -72% | -$771K | 0.08% | 35 |
|
|
2024
Q4 | $957K | Sell |
10,363
-971
| -9% | -$87.4K | 0.23% | 27 |
|
|
2024
Q3 | $950K | Buy |
+11,334
| New | +$865K | 0.2% | 28 |
|
|
2024
Q2 | – | Sell |
-21,502
| Closed | -$1.43M | – | 57 |
|
|
2024
Q1 | $1.58M | Sell |
21,502
-3,374
| -14% | -$259K | 0.37% | 25 |
|
|
2023
Q4 | $2.02M | Sell |
24,876
-5,262
| -17% | -$409K | 0.51% | 25 |
|
|
2023
Q3 | $2.26M | Sell |
30,138
-890
| -3% | -$68.5K | 0.66% | 24 |
|
|
2023
Q2 | $2.39M | Sell |
31,028
-3,016
| -9% | -$241K | 0.66% | 24 |
|
|
2023
Q1 | $2.82M | Sell |
34,044
-375
| -1% | -$31.1K | 0.87% | 26 |
|
|
2022
Q4 | $2.95M | Sell |
34,419
-1,927
| -5% | -$153K | 1.1% | 24 |
|
|
2022
Q3 | $2.24M | Sell |
36,346
-1,254
| -3% | -$79.1K | 0.87% | 26 |
|
|
2022
Q2 | $2.32M | Sell |
37,600
-2,107
| -5% | -$130K | 0.89% | 26 |
|
|
2022
Q1 | $2.36M | Sell |
39,707
-7,364
| -16% | -$471K | 0.67% | 26 |
|
|
2021
Q4 | $3.29M | Hold |
47,071
| – | – | 0.95% | 23 |
|
|
2021
Q3 | $3.29M | Sell |
47,071
-2,617
| -5% | -$184K | 0.94% | 23 |
|
|
2021
Q2 | $3.42M | Sell |
49,688
-1,220
| -2% | -$81.5K | 0.97% | 23 |
|
|
2021
Q1 | $3.29M | Sell |
50,908
-89
| -0.2% | -$5.74K | 1.06% | 23 |
|
|
2020
Q4 | $2.97M | Sell |
50,997
-2,212
| -4% | -$133K | 0.95% | 24 |
|
|
2020
Q3 | $3.36M | Sell |
53,209
-1,774
| -3% | -$123K | 1.2% | 20 |
|
|
2020
Q2 | $4.23M | Sell |
54,983
-1,941
| -3% | -$149K | 1.67% | 16 |
|
|
2020
Q1 | $4.26M | Sell |
56,924
-3,343
| -6% | -$231K | 2.27% | 14 |
|
|
2019
Q4 | $3.92M | Sell |
60,267
-3,953
| -6% | -$257K | 1.77% | 20 |
|
|
2019
Q3 | $4.07M | Sell |
64,220
-1,536
| -2% | -$100K | 2.04% | 18 |
|
|
2019
Q2 | $4.4M | Sell |
65,756
-10,796
| -14% | -$710K | 2.09% | 19 |
|
|
2019
Q1 | $4.98M | Sell |
76,552
-13,652
| -15% | -$907K | 2.44% | 14 |
|
|
2018
Q4 | $5.64M | Sell |
90,204
-926
| -1% | -$64.7K | 3.26% | 9 |
|
|
2018
Q3 | $7.04M | Sell |
91,130
-215
| -0.2% | -$16.2K | 3.2% | 8 |
|
|
2018
Q2 | $6.47M | Sell |
91,345
-2,261
| -2% | -$160K | 3.39% | 8 |
|
|
2018
Q1 | $7.06M | Sell |
93,606
-2,228
| -2% | -$177K | 3.92% | 8 |
|
|
2017
Q4 | $6.87M | Sell |
95,834
-208
| -0.2% | -$15.8K | 3.8% | 8 |
|
|
2017
Q3 | $7.78M | Sell |
96,042
-329
| -0.3% | -$25.2K | 4.47% | 7 |
|
|
2017
Q2 | $6.82M | Buy |
96,371
+480
| +0.5% | +$31.9K | 4.18% | 8 |
|
|
2017
Q1 | $6.51M | Sell |
95,891
-1,113
| -1% | -$78.3K | 4.2% | 8 |
|
|
2016
Q4 | $6.95M | Sell |
97,004
-1,883
| -2% | -$140K | 4.92% | 6 |
|
|
2016
Q3 | $7.82M | Sell |
98,887
-1,133
| -1% | -$92K | 5.17% | 5 |
|
|
2016
Q2 | $8.34M | Sell |
100,020
-1,477
| -1% | -$131K | 5.89% | 5 |
|
|
2016
Q1 | $9.32M | Sell |
101,497
-2,717
| -3% | -$245K | 6.31% | 3 |
|
|
2015
Q4 | $10.5M | Sell |
104,214
-1,092
| -1% | -$114K | 6.75% | 4 |
|
|
2015
Q3 | $10.3M | Sell |
105,306
-2,487
| -2% | -$276K | 7% | 4 |
|
|
2015
Q2 | $12.6M | Sell |
107,793
-777
| -0.7% | -$84.9K | 7.49% | 3 |
|
|
2015
Q1 | $10.7M | Buy |
108,570
+124
| +0.1% | +$12.6K | 6.21% | 4 |
|
|
2014
Q4 | $10.2M | Sell |
108,446
-367
| -0.3% | -$38K | 6.69% | 4 |
|
|
2014
Q3 | $11.6M | Sell |
108,813
-886
| -0.8% | -$86.8K | 8.06% | 2 |
|
|
2014
Q2 | $9.1M | Sell |
109,699
-138
| -0.1% | -$10.7K | 6.43% | 3 |
|
|
2014
Q1 | $7.78K | Sell |
109,837
-2,681
| -2% | -$210K | 5.22% | 4 |
|
|
2013
Q4 | $8.45M | Sell |
112,518
-2,117
| -2% | -$147K | 6.35% | 3 |
|
|
2013
Q3 | $7.21M | Sell |
114,635
-621
| -0.5% | -$37.1K | 5.65% | 4 |
|
|
2013
Q2 | $5.91M | Buy |
+115,256
| New | +$6.01M | 5.07% | 5 |
|
Other funds holding GILD
VCM
VPM
Bender Robert & Associates's GILD Position: Q1 2026 in Review
Bender Robert & Associates held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,819 shares worth $393K. The position accounts for 0.09% of the portfolio, ranked #34.
Bender Robert & Associates first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $12.6M in Q2 2015. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Bender Robert & Associates held 2,819 shares of Gilead Sciences worth $393K as of Q1 2026.
- Bender Robert & Associates left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.09% of Bender Robert & Associates's portfolio in Q1 2026, its #34 holding.
- Bender Robert & Associates first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- Bender Robert & Associates's Gilead Sciences position peaked at $12.6M in Q2 2015.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Bender Robert & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.